StemCell Therapy

2019 Celibate Clergy Candidatesfor Election to the Episcopacyof the Greek Orthodox Archdiocese of America

Updated on Oct.17, 2019

Download as PDF

Current Assignment: Transfiguration Of Christ Church, Mattituck, NYDirect Archdiocesan District

Date of birth: May 15, 1968Education: B.A., Hellenic College, Brookline, MA (1990)M.Div., Holy Cross, Brookline, MA (1993)

Ordinations/OffikionTo Diaconate: April 19, 1995To Priesthood: June 18, 1995Archimandrite: August 5, 2018

Current Assignment: Holy Cross Church, Whitestone, NYDirect Archdiocesan District

Date of birth: August 18, 1969Education: B.S., Computer Technology, Northeastern University, Boston, MA (1994)M.Div., Holy Cross, Brookline, MA (2004)

Ordinations/OffikionTo Diaconate: August 17, 2003To Priesthood: August 24, 2003Archimandrite: April 15, 2006

Current Assignment: Chancellor, Metropolis of Chicago

Date of birth: October 4, 1952Education: B.A., Hellenic College, Brookline, MA (1975)M.Div., Holy Cross, Brookline, MA (1978)

Ordinations/OffikionTo Diaconate: Sep. 14, 1980To Priesthood: October 5, 1980Archimandrite: May 12, 1985

Current Assignment:Saint John the Baptist Church, New York, NYDirect Archdiocesan District

Date of birth: November 15, 1945Education: A.A., Philosophy/Psychology, Kingsborough Community College, Brooklyn, NY (1992)B.A., Byzantine & Modern Greek Studies, Queens College, Queens, NY (1998)M.Div., Holy Cross, Brookline, MA (2005)

Ordinations/OffikionTo Diaconate: March 27, 2005To Priesthood: September 18, 2005Archimandrite: January 7, 2012

Current Assignment:Saint George Cathedral, Philadelphia, PAMetropolis of New Jersey

Date of birth: September 4, 1964Education: Lic., Theology, Aristoteleion University, Thessaloniki, GR (1991)M.A. Theology, Belford University School of Theology, Humble, TX (2008)M.A. Theology, Aristoteleion University, Thessaloniki, GR (2014)M.A. Ecclesiastical History, Seton Hall University-Immaculate Conception Theological Seminary (2015)PhD. Aristoteleion University, Thessaloniki, GR (2018)

Ordinations/OffikionTo Diaconate: November 24, 1985To Priesthood: January 12, 1992Archimandrite: January 12, 1992

Current Assignment:Saint George Church, Downey, CAMetropolis of San Francisco

Date of birth: August 13, 1957Education:strong> B. S., Biology, University of Richmond, VA (1979)M.S., Biology, University of Richmond, VA (1981)M.Div., Holy Cross, Brookline, MA (1987)

Ordinations/OffikionTo Diaconate: December 14, 1991To Priesthood: December 15, 1991Archimandrite: July 23, 1995

Current Assignment:Hellenic College/Holy Cross, Brookline, MADirect Archdiocesan District

Date of birth: June 7, 1954Education: M.Div., Holy Cross, Brookline, MA (1979)M.A., Byzantine History, Penn State, PA (1986)Ph.D., Byzantine History, Penn State, PA (1992)

Ordinations/OffikionTo Diaconate: December 9, 1979To Priesthood: December 23, 1979Archimandrite: May 16, 1998

Current Assignment: Saint George Church, Piscataway, NJMetropolis of New Jersey

Date of birth: December 4, 1964Education: B.A., Modern Languages, Citadel University, Charleston, SC (1987)M.Div., Holy Cross, Brookline, MA (1990)

Ordinations/OffikionTo Diaconate: February 2, 1991To Priesthood: May 11, 1996Archimandrite: May 11, 1996

Current Assignment: Kimisis Tis Theotokou Church, Brooklyn, NYDirect Archdiocesan District

Date of birth: September 11, 1944Education: B.A., Hellenic College, Brookline, MA (1973)M.Div. and S.T.M., Holy Cross, Brookline, MA (1974)

Ordinations/OffikionTo Diaconate: May 6, 1973To Priesthood: November 4, 1974Archimandrite: May 21, 1980

Current Assignment: Saints Constantine & Helen Church, Palos Hills, ILMetropolis of Chicago

Date of birth: April 14, 1967Education: B.A., Hellenic College, Brookline, MA (1985)M.Div., Holy Cross School of Theology, Brookline, MA (1992)

Ordinations/OffikionTo Diaconate: December 19, 2010To Priesthood: March 20, 2011Archimandrite: January 6, 2017

Current Assignment: Saint Barbara Church, Durham, NCMetropolis of Atlanta

Date of birth: March 9, 1957Education: B.A., Hellenic College, Brookline, MA (1980)M.Div., Holy Cross, Brookline, MA (1983)

Ordinations/OffikionTo Diaconate: September 14, 1986To Priesthood: October 19, 1986Archimandrite: June 6, 1999

Current Assignment: Saint Nicholas Church, Oak Lawn, ILMetropolis of Chicago

Date of birth: January 22, 1976Education: B.A., Hellenic College, Brookline, MA (2003)M.Div., Holy Cross, Brookline, MA (2006)

Ordinations/OffikionTo Diaconate: July 2, 2006To Priesthood: December 3, 2006Archimandrite: December 6, 2016

Current Assignment: Annunciation Cathedral, Baltimore, MDMetropolis of New Jersey

Date of birth: July 30, 1965Education: B.A., Hellenic College, Brookline, MA (1992)M.Div., Holy Cross, Brookline, MA (1994)

Ordinations/OffikionTo Diaconate: February 11, 1996To Priesthood: June 9, 1996Archimandrite: August 4, 2002

Current Assignment: Holy Apostles/Saints Peter & Paul Church, Haverhill, MAMetropolis of Boston

Date of birth: August 5, 1965Education: B.A., Hellenic College, Brookline, MA (1987)M.Div., Holy Cross, Brookline, MA (1990)ThD., Aristotelion University (2017)

Ordinations/OffikionTo Diaconate: January 30, 1991To Priesthood: February 17, 1991Archimandrite: December 31, 1996

Current Assignment: Holy Trinity Cathedral, Salt Lake City, UTMetropolis of Denver

Date of Birth: August 25, 1969Education: B.A., Hellenic College, Brookline, MA (1996)M.Div., Holy Cross, Brookline, MA (1999)

Ordinations/OffikionTo Diaconate: September 14, 1999To Priesthood: December 5, 1999Archimandrite: March 24, 2004

Current Assignment: Transfiguration of Christ Church, Corona, NYDirect Archdiocesan District

Date of Birth: October 11, 1964Education: B.A., Political Science, New York Institute of Technology, New York, NYCertificate, Antiochian House of Studies (2010)M.Div., Holy Cross, Brookline, MA (2015)

Ordinations/OffikionTo Diaconate: November 13, 2010To Priesthood: August 6, 2015Archimandrite: November 30, 2015

Current Assignment: Unassigned

Date of birth: January 1, 1958Education: M.A., Church Services, Hellenic College, Brookline, MA (1986)M.Div, Holy Cross, Brookline, MA (2007)After Hellenic College (1986) he traveled to the Monastery of Archangel Michael, Rhodos, where he was tonsured a monastic on October 21, 1991.

Ordinations/OffikionTo Diaconate & Priesthood: October 11, 1992 (Monastery of Archangel Michael, Rhodos)Archimandrite: October 20, 1994 (Church of St. Gerasimos, Pylona, Rhodos)NOTE: In 2015 incardinated into the Greek Orthodox Archdiocese of America from the Greek Orthodox Archdiocese of New Zealand. (Note: The number of years of service listed in the GOA Charter is no less than 5 years in the GOA.)

Current Assignment: Saint Demetrios Cathedral, Astoria, NYDirect Archdiocesan District

Date of birth: June 6, 1967Education: B.S., Electrical Engineering, Polytechnic University, NYC (1990)M.S., Electrical Engineering, Polytechnic University, NYC (1995)M.Div., St. Vladimirs Seminary, Crestwood, NY (2000)

Ordinations/OffikionTo Diaconate: June 16, 2002To Priesthood: January 18, 2004Archimandrite: January 18, 2004

Current Assignment: Three Hierarchs Church, Brooklyn, NYDirect Archdiocesan District

Date of birth: July 23, 1940Education: B.A., St. Johns University, Queens, NY (1962)M.Div., Holy Cross, Brookline, MA (1966)Lic., Theology, Aristotelion University, Thessaloniki, GR (1974)Diploma, Theology, Ecumenical Institute at Bossey, University de Geneve (1975)

Ordinations/OffikionTo Diaconate: January 30, 1966To Priesthood: May 29, 1966Archimandrite: May 29, 1971

Current Assignment: Lay Profession (Opthalmologist)Metropolis of New Jersey

Date of birth: April 22, 1977Education: B.A., Biology, Cornell University, Ithaca, NY (1998)MS, Science, SUNY, New York, NY (2003)O.D., Opthalmology, SUNY, New York, NY (2003)M.Th., St. Vladimirs Orthodox Seminary, Yonkers, NY (2010)

Ordinations/OffikionTo Diaconate: December 27, 2010To Priesthood: March 6, 2016Archimandrite: December 24, 2016

Current Assignment: Saints Constantine & Helen Church, Boise, IDMetropolis of Denver

Date of birth: November 7, 1945Education: Diploma*, Theology, St. Tikhons Seminary, South Canaan, PA (1973)B.A., Sociology, Kings College, Wilkes-Barre, PA (1974)* St Tikhons was granted the right to confer the M.Div. in 1988

Ordinations/OffikionTo Diaconate: December 21, 1975To Priesthood: October 3, 1976Archimandrite: November 4, 2001

Current Assignment: Saint George Cathedral, Manchester, NHMetropolis of Boston

Date of birth: April 21, 1957Education: B.S., Business Administration, Western New England College, Springfield, MA (1979)M.Div., Holy Cross, Brookline, MA (2005)

Ordinations/OffikionTo Diaconate: August 22, 2004To Priesthood: May 15, 2005Archimandrite: January 10, 2010

Current Assignment: Saint Anna Church, Roseville, CAMetropolis of San Francisco

Date of birth: September 20, 1971Education: B.A., Hellenic College, Brookline, MA (1993)M.Div., Holy Cross, Brookline, MA (1996)M.S., Science, Northeastern University, Boston, MA (1996)

Ordinations/OffikionTo Diaconate: November 17, 1996To Priesthood: February 2, 1997Economos: July 25, 2013

( )

. . (). . (). . (). . (). . (). . (). . (). . ()

. . (). . (). . (). . ()

, . . (). . (). . (). . (). . (). . (Katre)

Read the original post:
2019 Celibate Clergy Candidates for Election to the Episcopacy - Official Documents - Greek Orthodox Archdiocese of America

Ambulatory Healthcare IT Market report uses a range of steps for collecting, recording, analysing and interpreting market data to make this report all-inclusive. market report also endows with the list of the leading competitors and their moves such as joint ventures, acquisitions, and mergers etc.

Ambulatory Healthcare IT Market research report study presents data corralled through primary and secondary research methodologies exploring the global market. The detailed data provided in the report and the industry standard models use to analyze it make this industry report highly beneficial for the clients. This Ambulatory Healthcare IT Market research report describes the market in detail in terms of economics and regulatory factors that are currently shaping the markets growth trajectory, the regional segmentation of the global market and an analysis of the markets downstream and upstream value and supply chains are also included in the report.

Get Sample Report With All Graphs & Charts: https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-ambulatory-healthcare-market

Ambulatory care is also referred as outpatient care. It is a medical care given on outpatient criteria such as consultation, rehabilitation, observation, intervention, diagnosis, and treatment services. Ambulatory care involves emergency care, primary care, ambulatory services, and others. In this intervention and surgery, overnight hospital stay is not required.

The Ambulatory Healthcare IT Market research report provides the comprehensive and in depth study of the market which sheds light on each segment and provides precise investigation considering attractiveness, demand production and sales volume and growth prospects. Moreover this Ambulatory Healthcare IT Market report features the segmentation analysis to facilitate clients with a shrewdness that helps them to select appropriate segments of the Ambulatory Healthcare IT Market

Global Ambulatory Healthcare IT Market By Type (Ambulatory Services, Primary Care Offices, Outpatient Departments, Emergency Departments, Surgical Specialty, Medical Specialty, Others), Modality (Hospital-affiliated, Freestanding), Surgery Type (Opthalmology, Orthopedics, Gastroenterology, Pain Management, Others), Application (Laceration Treatment, Bone Fracture Treatment, Emergency Care Service, Trauma Treatment), Geography (North America, South America, Europe, Asia-Pacific, Middle East & Africa) Industry Trends and Forecast to 2026

Avail The TOC Here, To Get Premium Insights About The Ambulatory Healthcare IT Market Report: https://www.databridgemarketresearch.com/toc/?dbmr=global-ambulatory-healthcare-market

Few of the major market competitors currently working in the global ambulatory healthcare IT market are AmSurg Corp, Surgical Care Affiliates, Surgery Partners, Healthway Medical Group, SurgCenter, Trillium Health Partners, Medical Facilities Corporation, Nueterra Capital, Aspen Healthcare, Suomen Terveystalo Oy, IntegraMed America, Inc., SHERIDAN HEALTHCARE, NueHealth, Athenahealth, GENERAL ELECTRIC, Optum, Inc., Apria Healthcare Group, Inc., DaVita Inc., LVL Medical, Fresenius Kabi AG, Sonic Healthcare among others.

Summary of the research report

Want Full Report? Make Enquiries: https://www.databridgemarketresearch.com/inquire-before-buying/?dbmr=global-ambulatory-healthcare-market

About Us

Data Bridge Market Research is a versatile market research and consulting firm with over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. Our coverage of industries include Medical Devices, Pharmaceuticals, Biotechnology, Semiconductors, Machinery, Information and Communication Technology, Automobiles and Automotive, Chemical and Material, Packaging, Food and Beverages, Cosmetics, Specialty Chemicals, Fast Moving Consumer Goods, Robotics, among many others.

Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. Get Customization and Discount on Report by emailing Corporatesales@databridgemarketresearch.com . We are content with our glorious 99.9 % client satisfying rate.

Contact Us

Data Bridge Market Research

US: +1 888 387 2818

UK: +44 208 089 1725

Hong Kong: +852 8192 7475Mail:Corporatesales@databridgemarketresearch.comhttps://databridgemarketresearch.com

Read more from the original source:
Ambulatory Healthcare IT Market Trends, Syndicated Reports With AmSurg Corp, Surgical Care Affiliates, Surgery Partners, Healthway Medical Group,...

Opthalmology Drugs and Devices Market Report is a complete assessment of current status, trends and respective shares of some of the most prominent players in this landscape. The study contains thoughtful insights, facts, Opthalmology Drugs and Devices historical data, and statistically supported and industry-validated market data. This Opthalmology Drugs and Devices report also explores Business models, Key strategies and Growth opportunities in upcoming years.

The Opthalmology Drugs and Devices market report examines the economic status and prognosis of worldwide and major regions, in the prospect of all players, types and end-user application/industries; this report examines the most notable players in major and global regions, also divides the Opthalmology Drugs and Devices market by segments and applications/end businesses.

Request for Free Sample Copy at: http://www.researchreportcenter.com/request-sample/1254902

Merck (US), Pfizer (US), Roche Holdings (Switzerland), Santen Pharmaceutical(Japan), Abbott Medical Optics (US), Alcon (Switzerland), Bausch & Lomb (US), Carl Zeiss Meditec (Germany), Essilor International S.A. (France), Johnson & Johnson (US), Nidek(Japan), Topcon Corporation (Japan)

Global Opthalmology Drugs and Devices Market insights cover traits, growth, and size, segmentation, regional retreats, competitive landscape, shares, trends, and plans. The attributes part of this Opthalmology Drugs and Devices report defines and explains the growth. The market size department gives industry earnings, covering the historical growth of this and predicting the long run. Opthalmology Drugs and Devices Drivers and restraints with the variables affecting the growth of this market. The segmentations divide the essential Opthalmology Drugs and Devices sub-industries that form the market.

North America, China, Rest of Asia-Pacific, UK, Europe, Central & South America, Middle East & Africa

Get Discount on this Report: http://www.researchreportcenter.com/check-discount/1254902

The Opthalmology Drugs and Devices analysis incorporates historical data from 2014 to 2019 and predictions until 2025 helping to make the reports a valuable resource for industry executives, promotion, product and sales managers, advisers, analysts, and different people trying to find vital Opthalmology Drugs and Devices industry data in readily accessible records with clearly exhibited tables and charts.

Customization of the Report: This report can be customized as per your needs for additional data or countries.Please connect with our sales team (sales@researchreportcenter.com)

The rest is here:
Opthalmology Drugs and Devices Market Professional Survey and In-Depth Analysis Research Report Foresight to 2025 - Finance Daily Tribune

Active Pharmaceutical Ingredients (API) market size was valued at USD 158.5 billion in 2016 and is projected to reach to USD 297.4 billion by 2026 at a CAGR of 6.5%.This is a comprehensive global report focused on the current and future prospects of the active pharmaceutical ingredients market. This report is a consolidation of primary and secondary research, which provides market size, share, dynamics, and forecast for various segments and sub-segments considering the macro and microenvironmental factors. An in-depth analysis of past trends, future trends, demographics, and technological advancements for the active pharmaceutical ingredients market has been done in order to calculate the growth rates for each segment and sub-segments.

An active pharmaceutical ingredient is a biologically active portion of a pharmaceutical drug intended to perform certain pharmacological actions or have prominent effects for the diagnosis, cure, treatment or prevention of chronic and acute diseases.

REQUEST FOR FREE SAMPLE REPORT: https://www.maximizemarketresearch.com/request-sample/1816

The rising prevalence of chronic diseases and increasing uptake of biopharmaceuticals is expected to majorly drive the market growth.

As per data published by the World Health Organization (WHO), chronic disease prevalence is anticipated to rise by 57.0% by the year 2020. The number of people suffering from diabetes in developing countries was 84.0 million in 1995, which is projected to increase by 2.5-fold to 228.0 million in 2025. Chronic diseases include diabetes, obesity, and cardiovascular diseases, cancer, neurological diseases, and other diseases; the rise in prevalence of these diseases are augmenting the demand for treatment that may support the market growth over the forecast period.

Furthermore, augmented demand for rapid-acting & efficient drugs and the emergence of innovative drug manufacturing facilities are expected to assist in market growth during the forecast period.

Loss of drug exclusivity is impeding the revenue growth!

Patent expiration is accountable for the huge loss for pharmaceutical firms in terms of revenue, which is anticipated to impede the market growth during the forecast period.

The biotech APIs segment is expected to witness significant market growth.

The biotech APIs segment is expected to register comparatively higher CAGR over thee forecast period owing to high R&D for novel biosimilar drugs, escalating demand for protein-based therapeutics, and rising key traditional manufacturers focus toward biological drugs.

The branded/innovative drugs segment spearheaded the market.

A surge in prescription rates and drug prices coupled with higher spending on R&D activities are expected to contribute to the dominance of the branded/innovative drugs segment.

The merchant manufacturers segment is expected to witness lucrative market growth.

Worldwide rising outsourcing of API/drug molecule formulation from drug manufacturers in order to eliminate the need for heavy investment in manufacturing processes.

North America is expected to hold a major chunk of the market during the forecast period.

North America is anticipated to hold substantial market share over next ten years owing to the presence of favorable government initiatives, changing lifestyle leads to the development of diseases, rising investment on R&D, and technological developments in drug manufacturing processes.

Key Highlights:

Active pharmaceutical ingredients market size analysis and forecast Comprehensive study and analysis of market drivers, restraints, and opportunities influencing the growth of the active pharmaceutical ingredients market Active pharmaceutical ingredients market segmentation on the basis of synthesis type, drug type, manufacturer type, therapeutic area, and geography (regional) Active pharmaceutical ingredients market strategic analysis with respect to individual growth trends, future prospects along with a contribution of various sub-market stakeholders have been considered under the scope of a study Active pharmaceutical ingredients market analysis and forecast for five major regions such as North America, Europe, Asia Pacific, Latin America, and MEA. Profiling of key industry players, their strategic perspective, market positioning and analysis of core competencies Competitive landscape of the key players operating in the active pharmaceutical ingredients market including competitive developments, investments, and strategic expansion

Years that have been considered for the study are as follows:

Base Year 2016 Estimated Year 2017 Forecast Period 2017 to 2026

For company profiles, 2016 has been considered as the base year. In cases, wherein information was unavailable for the base year, the years prior to it have been considered.

Research Methodology:

The market is estimated by triangulation of data points obtained from various sources and feeding them into a simulation model created individually for each market. The data points are obtained from paid and unpaid sources along with paid primary interviews with key opinion leaders (KOLs) in the market. KOLs from both, demand and supply side were considered while conducting interviews to get an unbiased idea of the market. This exercise was done at a country level to get a fair idea of the market in countries considered for this study. Later this country-specific data was accumulated to come up with regional numbers and then arrive at the market value for active pharmaceutical ingredients market.

DO INQUIRY BEFORE PURCHASING REPORT HERE: https://www.maximizemarketresearch.com/inquiry-before-buying/1816

Some of the key players of the active pharmaceutical ingredients market include:

AbbVie Inc. Bristol-Myers Squibb Company Boehringer Ingelheim GmbH Cipla Inc. Merck & Co., Inc. Eli Lilly and Company Mylan N.V. Teva Active Pharmaceuticals Industries Ltd. Aurobindo Pharma Sun Pharmaceutical Industries, Ltd. Dr. Reddys Laboratories Ltd. Albemarle Corporation

Key Target Audience:

Healthcare companies Corporate healthcare entities Government agencies Market research and consulting firms Venture capitalists Technical StudentsScope of the Active Pharmaceutical Ingredients Market Report:

The research report segments the active pharmaceutical ingredients market based on synthesis type, drug type, manufacturer type, therapeutic area, and geography.Active Pharmaceutical Ingredients Market, By Synthesis Type

Biotech Monoclonal Antibodies Recombinant Proteins Vaccines SyntheticActive Pharmaceutical Ingredients Market, By Drug Type

Branded Drugs Generic Drugs Over-the-counter (OTC) DrugsActive Pharmaceutical Ingredients Market, By Manufacturer Type

Captive Manufacturers Merchant ManufacturersActive Pharmaceutical Ingredients Market, By Therapeutic Area

Cardiology Pulmonology Opthalmology Neurology Oncology Orthopedics OthersActive Pharmaceutical Ingredients Market, By Geography

North America U.S. Canada Europe UK Germany France Italy Spain Rest of Europe Asia Pacific Japan China India Rest of Asia Pacific Latin America Brazil Mexico Rest of Latin America MEA South Africa Saudi Arabia Rest of MEA

Geographic Analysis:

Breakdown of North America Active Pharmaceutical Ingredients Market Breakdown of Europe Active Pharmaceutical Ingredients Market Breakdown of Asia Pacific Active Pharmaceutical Ingredients Market Breakdown of Latin America Active Pharmaceutical Ingredients Market Breakdown of MEA Active Pharmaceutical Ingredients Market

MAJOR TOC OF THE REPORT

Chapter One: Active Pharmaceutical Ingredients (API) Market Overview

Chapter Two: Manufacturers Profiles

Chapter Three: Global Active Pharmaceutical Ingredients (API) Market Competition, by Players

Chapter Four: Global Active Pharmaceutical Ingredients (API) Market Size by Regions

Chapter Five: North America Active Pharmaceutical Ingredients (API) Revenue by Countries

Chapter Six: Europe Active Pharmaceutical Ingredients (API) Revenue by Countries

Chapter Seven: Asia-Pacific Active Pharmaceutical Ingredients (API) Revenue by Countries

Chapter Eight: South America Active Pharmaceutical Ingredients (API) Revenue by Countries

Chapter Nine: Middle East and Africa Revenue Active Pharmaceutical Ingredients (API) by Countries

Chapter Ten: Global Active Pharmaceutical Ingredients (API) Market Segment by Type

Chapter Eleven: Global Active Pharmaceutical Ingredients (API) Market Segment by Application

Chapter Twelve: Global Active Pharmaceutical Ingredients (API) Market Size Forecast (2019-2026)

Browse Full Report with Facts and Figures of Active Pharmaceutical Ingredients (API) Market Report at: https://www.maximizemarketresearch.com/market-report/active-pharmaceutical-ingredients-api-market/1816/

About Us:

Maximize Market Research provides B2B and B2C market research on 20,000 high growth emerging technologies & opportunities in Chemical, Healthcare, Pharmaceuticals, Electronics & Communications, Internet of Things, Food and Beverages, Aerospace and Defense and other manufacturing sectors.

Contact info:

Name: Lumawant Godage

Organization: MAXIMIZE MARKET RESEARCH PVT. LTD.

Email: sales@maximizemarketresearch.com

Contact: +919607065656/ +919607195908

Website: http://www.maximizemarketresearch.com

The rest is here:
Active Pharmaceutical Ingredients (API) Market Global Industry Analysis and Forecast (2017-2026 - Markets Gazette

It's almost time for the American Academy of Opthalmology's (AAO) annual meeting again, and this year's event will contain some high-stakes presentations. This year, all three of these biopharmaceutical companies will present clinical trial results that could send their stock prices soaring -- or tumbling.

Data source: Company Filings, Yahoo! Finance.

Which stocks have the best chance to climb this week? Here's what to look out for when investigators from each company present their results at AAO.

Image source: Getty Images.

Ophthalmologists have been treating age-related macular degeneration (AMD) and similar causes of blindness with vascular endothelial growth factor (VEGF) inhibitors like Eylea fromRegeneronfor a long time. Sadly, many patients continue losing their sight despite VEGF treatment and Kodiak has an elegant solution to the problem.

Ophthalmologists would like to apply a VEGF treatment to the retina every few days but nobody wants to visit the doctor to get a needle in the eye more often than necessary. Four- and eight-week intervals are the norm and toward the end of each interval, there are days where treatments have already been depleted. That allows new blood vessels to begin invading the retina until the next generation.

On Friday, Oct. 11, 2019, Kodiak will present durability data from an ongoing study with patients that are losing their vision to AMD or a related disorder. The company's lead candidate, KSI-301 is a VEGF antibody with long, heavy hair extensions calledphosphorylcholine. That's the same biopolymer used in drug-eluting stents.

Kodiak's KSI-301 appeared to work well after at a 12-week checkup, but that's not very long. If durability data presented on Friday continues to impress, this stock's terrific run-up in 2019 could go much further.

Image source: Getty Images.

In September, Adverum Biotechnologies stock sank after the company reported 24-week data for the first six patients treated with a single injection of ADVM-022, its experimental gene therapy for many of the same AMD patients that Kodiak's aiming at. A one-time treatment that keeps invading blood vessels at bay for the rest of a patient's life would be a welcome improvement, but patients experienced an average loss of two letters when their best-corrected visual acuity (BCVA) scores were assessed.

While Adverum hailed the results as a success because none of the patients received rescue injections with a regular VEGF treatment, some observers wondered why rescue injections weren't provided. According to Adverum, AMD wasn't responsible for the observed vision losses, and the gene therapy actually worked as expected.

On Friday, Oct. 11, Adverum will present more details from the disappointing 24-week data that hammered the stock a month earlier. If the company can convince investors that the results they saw earlier contained strong signs of encouragement, the stock could regain some of last month's losses.

Unfortunately, ADVM-022 doesn't appear to work any better than AVA-101, another experimental gene therapy that Adverum quit developing years ago when the company was still named Avalanche Biotechnologies. Investors should know that the company ended up settling a class action lawsuit for $13 million rather than try to defend itself against allegations of false statements and omissions of important information that would have sent investors running for the hills much earlier than they did in 2015.

Image source: Getty Images.

At last year's AAO conference, Regenexbio stock soared after the company presented early clinical trial results for RGX-314, an experimental gene therapy for AMD patients. In May, the company completed dosing all 42 patients in the trial with five escalating dosages of RGX-314. On Friday, Oct. 11, Regenexbio will present 18-month data for cohort three and interim data from cohorts four and five.

Only three out of six patients in group three were still VEGF injection-free 18 months after a single dose of RX-314, so success with a larger dosage is a must for this program.If interim data from cohorts four and five lead to a stronger response that keeps invasive blood vessel formation from robbing patients of their vision.

So far, we've seen dosage-dependent responses in cohorts one through three, and a continuation of this trend in cohorts four and five could send this biotech stock through the roof.

Image source: Getty Images.

While Adverum's gene therapy seems headed for further trouble, Regenexbio's gene therapy has a pretty good shot at impressing investors later this week. Further down the line, however, Kodiak Sciences probably has the best chance to successfully launch a new drug for the treatment of AMD and related causes of blindness.

There's a lot to like about single-shot solutions from Adverum and Regenexbio, but they could end up solving a problem that isn't really a big problem anymore. That's because Kodiak's candidate might be able to outperform standard care with just a couple of injections per year instead of every four to 12 weeks as is the norm today.

View original post here:
3 Blindness-Fighting Biotech Stocks That Could Surge This Week - The Motley Fool

The Ambulatory Healthcare IT Market report has been crafted carefully to provide the latest insights into the significant aspects of the Market. This Ambulatory Healthcare IT Market research report is the exhaustive analysis of the market across the world. It offers an overview of the market including its definition, key drivers, key market players and key segments. In addition, the study presents statistical data on the status of the market and hence is a valuable source of guidance for companies and individuals interested in the Industry. Market segmentations break down the key sub sectors which make up the market.

Download Sample Report With All Graphs & Charts (Updated Values Are Listed In Sample Report): https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-ambulatory-healthcare-market

Ambulatory care is also referred as outpatient care. It is a medical care given on outpatient criteria such as consultation, rehabilitation, observation, intervention, diagnosis, and treatment services. Ambulatory care involves emergency care, primary care, ambulatory services, and others. In this intervention and surgery, overnight hospital stay is not required.

The report highly involves chapter wise explanation for every aspect of the market wherein the drivers, trends, opportunities, leading and trending segments are discussed in detail with specific examples. Profiles of leading players are also discussed along with their business expansion strategies.

Few of the major market competitors currently working in the global ambulatory healthcare IT market are AmSurg Corp, Surgical Care Affiliates, Surgery Partners, Healthway Medical Group, SurgCenter, Trillium Health Partners, Medical Facilities Corporation, Nueterra Capital, Aspen Healthcare, Suomen Terveystalo Oy, IntegraMed America, Inc., SHERIDAN HEALTHCARE, NueHealth, Athenahealth, GENERAL ELECTRIC, Optum, Inc., Apria Healthcare Group, Inc., DaVita Inc., LVL Medical, Fresenius Kabi AG, Sonic Healthcare among others.

Get TOC To Analyze Major Sections Of The Ambulatory Healthcare IT Market Report: https://www.databridgemarketresearch.com/toc/?dbmr=global-ambulatory-healthcare-market

The predictions featured in this report have been derived using proven research methods and standards. With this data, the research report serves as a source of information and analysis for every segment of the market, including but not restricted to: local markets, product, and application.

Global Ambulatory Healthcare IT Market By Type (Ambulatory Services, Primary Care Offices, Outpatient Departments, Emergency Departments, Surgical Specialty, Medical Specialty, Others), Modality (Hospital-affiliated, Freestanding), Surgery Type (Opthalmology, Orthopedics, Gastroenterology, Pain Management, Others), Application (Laceration Treatment, Bone Fracture Treatment, Emergency Care Service, Trauma Treatment)

Want Full Report? Enquire Here: https://www.databridgemarketresearch.com/inquire-before-buying/?dbmr=global-ambulatory-healthcare-market

About Us

Data Bridge Market Research is a versatile market research and consulting firm with over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. Our coverage of industries include Medical Devices, Pharmaceuticals, Biotechnology, Semiconductors, Machinery, Information and Communication Technology, Automobiles and Automotive, Chemical and Material, Packaging, Food and Beverages, Cosmetics, Specialty Chemicals, Fast Moving Consumer Goods, Robotics, among many others.

Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. Get Customization and Discount on Report by emailing Corporatesales@databridgemarketresearch.com . We are content with our glorious 99.9 % client satisfying rate.

Contact Us

Data Bridge Market Research

US: +1 888 387 2818

UK: +44 208 089 1725

Hong Kong: +852 8192 7475Mail:Corporatesales@databridgemarketresearch.comhttps://databridgemarketresearch.com

Read the rest here:
Ambulatory Healthcare IT Market Insights, Online Research With AmSurg Corp, Surgical Care Affiliates, Surgery Partners, Healthway Medical, SurgCenter,...

The renowned surgical director of our practice, Christopher T. Coad, MD, FACS has gathered a team of highly gifted staff to create a boutique practice in New York City that brings a comprehensive approach to patients vision, LASIK and cosmetic needs. Our state-of-the-artfacility boasts an art gallery in the reception area, a comfortable relaxed environment suggestive of a spa and an in-office surgical suite. Our doctors train other physicians and are often featured in the press.

Dr. Coad specializes in the most advanced vision correction procedures including LASIK, PRK, Visian ICL, premium intraocular lens implants, and no-stitch cataract surgery. He has been performing laser vision correction since its approval by the FDA in the early 1990s. Dr. Coad has been named a Top Doctor in Ophthalmology by Castle Connolly Medical.

Competitive prices, extended office hours, participation in most health care plans, and interest-free financing have helped us gain the trust of over 60,000 patients.

Giving Back to the CommunityWeve been serving our community for two decades and donate to organizations such as amfAR, Callen Lorde, ESPA, glaad, HRC, and The Little Baby Face Foundation. We have special programs to treat patients in financial need who suffer from HIV related lipodystrophy and are setting up a foundation to help treat victims of bullying and spousal abuse in the LGBT community. Our waiting room also serves as an art gallery to exhibit the work of local artists and fund charities. To find out more about the ways we support art and our community, visit us on Facebook.

Chelsea Eye Ophthalmology is downtown Manhattans leading eye care andlaser visioncenter. Founded in 1989, the facility expanded 10 years later to its present location in the heart of Chelsea's gallery district in NYC.

Dr. Coad specializes in the most advanced vision correction procedures includingLASIK,PRK,Visian ICL,premium intraocular lens implants, andno-stitch cataract surgery. He has been performing laser vision correction since its approval by the FDA in the early 1990s.

Dr. Jason Cheung, works closely with Dr. Coadto provide comprehensive eye care includingcontact lens servicesand treatments formedical eye conditions.

Competitive prices, extended office hours, participation in mosthealth care plans, andinterest-free financinghave helped us gain the trust of over 60,000 patients.

Giving Back to the CommunityWeve been serving our community for two decades and donate to organizations such as amfAR, Callen Lorde, ESPA, glaad, HRC, and The Little Baby Face Foundation. We have special programs to treat patients in financial need who suffer from HIV related lipodystrophy and are setting up a foundation to help treat victims of bullying and spousal abuse in the LGBT community. Our waiting room also serves as anart galleryto exhibit the work of local artists and fund charities. To find out more about the ways we support art and our community,visit us on Facebook.

"Im so happy I chose Dr. Coad as my physician for LASIK. I have been his patient for many years and we both felt the time was right for me to have the surgery." - Tracie Max Sachs, 5x World CupChampion Speed Skier, LASIK Patient

"I have had no problems, I see perfectly and I wish I had done this years agoDr. Coad is the best!!" - Mario Cantone, Actor, LASIK Patient

Read More Testimonials...

Read the rest here:
Chelsea Eye Ophthalmology, PLLC - LASIK Surgeon & LASIK ...

Your child's ability to see the world depends on healthy eyes. At Children's National Health System, our pediatric ophthalmologists are experts at diagnosing and treating complex eye problems, congenital disorders and rare eye conditions, such as strabismus, childhood cataract and glaucoma. We offer comprehensive care for patients of all ages, from newborns to young adults.

Not all eye doctors are the same. Eye conditions that threaten your child's sight, such as retinopathy of prematurity, require the expertise of a well-trained and experienced pediatric ophthalmologist.

Our team includes board-certified ophthalmologists with advanced fellowship training who specialize in pediatric care. Our pediatric ophthalmologists are trained to recognize and manage eye diseases and disorders in children whose vision is still developing.

Features of our ophthalmology program include:

Every year, our ophthalmology team treats thousands of children and adults with strabismus or misalignment of the eyes. That high volume allows us to develop expertise, not only in the common problems such as crossing (esotropia) and wandering (exotropia) of the eyes, but also in the most complex cases, such as:

Each type of strabismus requires a different approach, and so does every patient. We use the results of a comprehensive eye exam and orthoptics evaluation to develop a personalized treatment specific to your child's age and diagnosis.

Surgery may be the best treatment option for some patients, with or without eyeglasses or patching. We take into account factors such as the type and severity of the strabismus and your child's age when making a recommendation. We will sit down and discuss the potential risks and benefits of surgery with you, so you can make the most informed choice. We schedule most evaluations and surgery on an outpatient basis.

We emphasize a multidisciplinary approach to care. That means, our program includes a team of experts specialized in all aspects of eye care so we can provide the most comprehensive care possible.

Learn more:

At Children's National, we use the most advanced equipment and techniques for accurate diagnostic tests and screenings. A comprehensive eye evaluation takes about two hours. Your ophthalmologist may order one or several of the following tests:

For more information or to schedule an appointment, please call 202-476-3015.

Read more here:
Ophthalmology | Children's National

Lahey Hospital & Medical Centers Department of Ophthalmology serves the needs of patients by providing comprehensive medical care. We seek to foster an environment of high caliber professionalism in order to exceed our patients expectations.

A team of more than 70 medical professionals provides a full range of eye care. Nearly 20 ophthalmology and optometry specialists work in proximity to each other, allowing interchange of talent. Examination rooms are adjacent to the operating suite to facilitate care.

In addition to providing routine eye examinations, staff diagnose and treat all aspects of eye disease in adolescents, adults and seniors. These include cataracts, glaucoma, cornea and external disease, laser vision correction, trauma, low vision, retinal and vitreous disease, oculoplastics and neuro-ophthalmology.

Patient undergoing an eye exam.The Department of Ophthalmology provides comprehensive eye care and complete medical and surgical treatment. The foundation of the department is an experienced, highly motivated staff whose mission has multiple goals:

Dr. Edward Connolly, who joined Lahey in 1969, and Dr. Joseph Bowlds, who joined in 1972, founded Ophthalmology Services at the then Lahey Clinic. The department was initially located on Commonwealth Avenue in Boston. Over the next 14 years, optometrists and ophthalmologists were hired.

By 1994, when the department was located in Burlington, it consisted of six full-time ophthalmologists, one part-time ophthalmologist, and five full-time optometrists. Today, the departments unique multidisciplinary approach to patient care involving the collaboration of ophthalmology and optometry specialists with different areas of expertise allows for cross-fertilization of talent, producing the very best in comprehensive patient care.

The Eye Institute, a dynamic eye care center housed within the Department of Ophthalmology, was conceived in the summer of 1994 as part of the re-engineering of the ophthalmology program, led by F. Denton Wertz III, MD, then the chair of the department. After opening at Lahey Medical Center, Peabody the Institutes comprehensive approach to vision care and medical and surgical diseases of the eyes made it popular with patients. In addition to providing state-of-the-art diagnostic capabilities in all areas of vision care, it is situated adjacent to the operating suite, facilitating the very best in care.

Ophthalmology services are also available through Lahey at its Arlington site, located at the former Symmes Hospital. In addition, a program providing subspecialized ophthalmology care for patients in Bermuda is currently under development.

Continue reading here:
Ophthalmology - lahey.org

What is ophthalmology?Ophthalmology is a branch of medicine which deals with the eyes and visual system, and diagnosing, treating, and preventing diseases and conditions affecting them.Ophthalmology is a mixed medical and surgical specialty, and deals with a diverse range of issues. Eye health services are very important, as eye problems, such as cataracts, are very common, affecting a large number of people across the UK, and as the population ages, the incidence of age-related macular degeneration (AMD) increases. If these diseases are caught early enough, they can be treated and managed with the expertise of ophthalmologists.What conditions does an ophthalmologist treat?Although the eye is a small organ, its importance cannot be overstated, and, due to the complexity of our visual mechanics, the eyes can be affected by a number of different problems and diseases. As such, ophthalmologists have to be trained to deal with a wide variety of visual problems. Some of these eye problems are very common for instance, cataract surgery is the second most common operation performed on the NHS in England.Some of the conditions ophthalmologists treat include:Which subspecialties are included under ophthalmology?Sub-specialty interests for ophthalmologists include:

See original here:
The best Ophthalmologists in 2019 | TopDoctors

If you are experiencing an eye emergency involving sudden vision loss or the acute onset of pain or double vision, call 911 or seek emergency care immediately. The UK Chandler Emergency Department has ophthalmology providers on call 24/7.

UK Advanced Eye Care provides expert eye care for all ages ranging from simple eye exams to diagnosing and treating the most complex eye diseases in a new state-of-the art facility.

Using the widest range and most up-to-date technology in the state, our fellowship-trained specialists are able to diagnose and treat various eye diseases and conditions including:

Having our entire team of optometrists, general ophthalmologists and specialists together in one location allows for improved efficiency, increased continuity of care, and ease of referrals for further testing, surgical consultation or treatment.

At UK Advanced Eye Care, we are proud of our patient care services. We are hiring full-time ophthalmic technicians and patient care coordinators. We offer competitive benefits and on-the-job training.

Contact Philip Moss if you are interested: 859-323-0729 or philip.moss@uky.edu.

Shriners Hospitals for Children Medical Center Lexington

110 Conn TerraceFourth and Fifth FloorsLexington, KY 40508

(Primary eye care and all subspecialty eye care)

UK HealthCare - Turfland

2195 Harrodsburg RoadFirst floorLexington, KY 40504

Monday - Friday: 8:00 am-5:00 pm

(Primary eye care)

PLEASE NOTE: UK Optical Shops at Shriners and Turfland are CLOSED. The providers of General Ophthalmology are still seeing patients as scheduled. See full notice

UK HealthCare Jessamine Eye Center

100 John Sutherland DriveSuite 3Nicholasville, KY 40356

UK Manchester Eye Care

231 White St.Manchester, KY 40962

(Primary eye care, retina and vitreous disorders)

UK HealthCare Eye Center - Richmond

920 Barnes Mills RoadSuite DRichmond, KY 40475

(Cornea and external diseases, glaucoma, pediatric ophthalmology, primary eye care, retina and vitreous disorders)

UK HealthCare - Baptist Health

1760 Nicholasville RoadSuite 203Lexington, KY 40503

(Corneal and external diseases, primary eye care, retina and vitreous disorders)

More here:
Advanced Eye Care | UK HealthCare

Dr. Pierre Guibor has been my trusted ophthalmologist for many years; gosh, I think it has been around 20 years, now. He used to have his office in Manhattan, just off Park Ave. Now, his office is (& has been for a while) inside Meadowlands Hospital Medical Center, in Secaucus, New Jersey, where he is Chief, Ophthalmology & Oculoplastic Surgeon.Years back, It was Dr. Guibor who showed me the unbelievably easy way to put drops in my eye. So simple ! No shock to the eye, no trauma, no drama. No tilting the head. Easy! Pain free. It is knowing & trusting the skill of Dr Guibor that keeps me calm when he explains that he is going to check the pressure in my eye. He has put a drop in each eye so that I won't feel the thing with the blue light that checks the pressure, but, I'm not blinking, since I'm not nervous, because I trust in his ability. Years ago, when Dr Guibor surgically removed an eyelid papilloma for me, in the hospital, I had total confidence in him. I was not worried about his surgical ability, that's for sure. Everything went well, I even went shopping briefly w/my friend afterwards. Having the big bandage over my eye was the most amazing shopping asset ever!! In the designer outlet shop, in Seacaucus , the shopping crowd, upon seeing my big bandage, parted, like the sea parted in the movie, "The Ten Commandments"....but, I digress, please forgive me. LOL I feel so very fortunate to know Dr. Guibor, and have him as my ophthalmologist because he is so very knowledgeable, with many years of experience. As important as experience and skill are, I strongly believe that it is equally important for a physician to treat patients with respect. From my own experience, as well as from my observations, I can tell you that he treats every patient with respect. He has taught many medical professionals & has taught in many locations around the world! So he knows a lot of eye specialists, which is to your benefit, as a patient. Think about it, let's say you were away on vacation, or business, & you needed an eye specialist , you could email or call Dr Guibor and ask if he could recommend someone. And chances are he just may know a skilled eye Dr where you happen to be. (And that's because Dr Guibor is one cool dude!...who happens to be a kind, talented, smart, eye surgeon.) He is a very cool person. I'm also so proud to let people know that he has taught his surgical skills to many medical professionals in countries where the opportunity to learn from such a well-respected eye surgeon is rare. I shall have to double check, but I think he has also been involved with Doctors Without Borders. The bottom line is, it is my personal, humble opinion, that you are in great, experienced, knowledgeable hands w/Dr. Pierre Guibor.And lastly, I am very particular when it comes to selecting a medical or dental professional. And that is an understatement. I take everything into consideration--how does the doctor speak to his/her staff...does he/she answer my questions, does he/she explain things, do I feel rushed, it all matters to me. I don't just want a good doctor, I want a good person, too! And I want a person who enjoys their work. In my opinion, when someone enjoys the work they do, they don't mind explaining things. Getting to Meadowlands Hospital by bus from Manhattan is easy . IT IS ONLY 20 MINUTES!! I take the NJ Transit bus #129, from The Port Authority Bus Terminal--the 2nd building, located on 41st Street (Not 42St). The building has Heartland Brewery on street level, see my photo. I enter at 8th Ave/West 41st Street, walk straight ahead, staying on the left side, and past Au Bon Pain, past the escalators & you'll see on your left the area, up a few steps, where you buy your bus ticket. I think my R/T tix today were $7. ALLOW ENOUGH EXTRA TIME FOR TIX & GETTING UPSTAIRS TO THE GATE WHERE BUS #129 will depart from. Today it was Gate 314. The ride is just 20 minutes to the front of the hospital. I ALWAYS TELL THE BUS DRIVER THAT I AM GOING TO MEADOWLANDS HOSPITAL WHEN I GET ON THE BUS. I do ring for the stop, too. THE BUS DOES NOT AUTOMATICALLY STOP ANYWHERE. YOU MUST RING FOR YOUR STOP. So it's a good idea to mention to the bus driver as you board the bus that you are going to Meadowlands Hospital. And lastly, if you want to see Dr Guibor, you need to call & make an appointment. OFFICE: 201-392-3438When you have a good , thorough eye exam, you have peace of mind. Did you know that sometimes other medical situations can be detected by way of a thorough eye exam? If you have been putting off an eye exam, for way too long & you know it, well then, maybe there's a reason you happen to see this.

Read the original:
Pierre Guibor, MD, PA - 25 Photos - Ophthalmologists - 55 ...

Dr. Hufnagel's Biography Dr. Hufnagel is a cornea-trained, board-certified ophthalmologist. He is a graduate of UCLA, Yale and Johns Hopkins Universities. Dr. Hufnagel has been recognized as a VISX STAR, an award granted only to the leading excimer laser surgeons in the United States. Dr. Hufnagel has participated in an FDA-sponsored investigation for LASIK surgery. His pioneering involvement with excimer lasers dates back to 1987 with published studies on the pathological aspects of laser surgery applied to the cornea. To date, he has performed several thousand laser vision correction procedures and tailors all surgeries to each patients individual needs. He is an instructor in IntraLASE bladeless LASIK surgical technique and actively teaches LASIK to other surgeons. After getting to know Dr. Marc Werner, we thought you might want to meet Dr. Thierry Hufnagel. If you still have questions for Dr. Hufnagel, like his opinions on the iFS laser or what his Ben and Jerrys ice cream flavor would be, let us know in the comments below. Where are you originally from? I hail from Paris (France, not Texas!) What is your favorite memory from your years at Johns Hopkins? My fondest memory about Hopkins? People were referred there from all over the world for advice and treatment. I once examined this very famous Chicago lawyer who came in for cataract surgery. He was referred to me by my mentor, Dr. Walter Stark. After the lawyer came in for surgery, I told Dr. Stark that I thought he shouldnt operate on the patient. I didnt think that patient had a cataract! After further testing, we found that the patients visual loss was actually from a brain tumor, not a cataract. From that day on, they all thought I was pretty smartvery funny! How many years have you been practicing laser surgery? I opened my first LASIK center in New York City at the Trump Tower in 1995 called Insight Vision. What made you pick ophthalmology, particularly LASIK, as a specialty? When you ask patients about LASIK, most of them will tell you its the best thing they ever did! Not getting married, not having children, but having LASIK done! Lots of people see their need for glasses or contacts as a serious disability. Providing people with the gift of sight is very rewarding. My first rotation in medical school was in a hospice with end-of-life cancer patients. I couldnt do anything to help except pushing the morphine. I felt pretty useless. I looked for the field where I thought I could be the most helpful. Obstetrics and bringing babies to life or ophthalmology and providing the gift of sight were the two options I looked into. Then by chance, I landed in the eye business, not the maternity ward! Where do you teach LASIK to other surgeons? We do all of the teaching in our office where we have a state-of-the-art facility. Your favorite thing about New York? Melting pot, for sure.

See the original post here:
Ophthalmologists near Brooklyn, NY - Eye Surgeon

Specialty Eye Care in Norfolk, Virginia

In practice for over 35 years, our mission at Virginia Ophthalmology Associates is to provide our patients with top quality eye care in a warm and comfortable environment. Our skill set covers the spectrum from routine eye care for newborns, children, and adults, to the surgical management of complex eye diseases requiring fellowship-level subspecialty training.

We offer comprehensive eye examinations, evaluation and treatment of cataracts, glaucoma, and diabetic retinopathy as well as state of the art ophthalmic surgery.

Dr. Joel Lall-Trail is fellowship trained in pediatric ophthalmology and adult strabismus and performs all aspects of pediatric eye care. He performs surgery on children and adults with eye muscle (strabismus) problems.

Dr. Mark Fernandez is a fellowship trained cornea specialist who performs cataract surgery, laser vision correction, corneal transplantation, pterygium surgery and repair of intraocular lens-related complications.

Dr. Arielle Spitze is fellowship trained in both glaucoma surgery and neuro-ophthalmology. She performs cataract surgery and surgical and laser treatment of glaucoma, as well as the diagnosis of diseases involving both the eye and brain.

Dr. Giovanni DiSandro is fellowship trained in surgery of the eyelids and orbit (Oculoplastics).

Dr. Peter Mitrev is fellowship trained in glaucoma surgery. He performs cataract surgery as well as surgical and laser treatment of glaucoma.

Our Ophthalmologists are all certified by the American Board of Ophthalmology.

Our optometrist, Dr. Ayesha Rahman, is experienced in fitting both soft and hard contact lenses as well as providing medical eye exams.

See the article here:
Virginia Ophthalmology Associates Specialty Eye Care in ...

LASIK in Norfolk Virginia Beach Chesapeake VA Highly Skilled in Laser Vision Correction

At Virginia Eye Consultants, we offer only the safest, most effective eye treatments available. Our team is composed of extensively trained eye care professionals who have particular expertise in laser vision correction. With procedures like LASIK and PRK becoming such well-known solutions for refractive errors, we take pride in educating our patients on these advanced laser options. Both LASIK and PRK are revolutionary procedures that have proven to significantly impact our patients lives, often eliminating their need to wear glasses or contact lenses.

Our highly skilled ophthalmologists are more than happy to discuss laser vision correction with you, answering any questions or concerns you may have.

Eliminate cloudy vision with laser surgery

Many of us will develop cataracts as we age, and if left untreated, this prevalent condition can lead to progressive vision loss. With laser cataract surgery, we can restore your eye health.

Say goodbye to glasses and contacts

If youre ready to eliminate the need for corrective eyewear, LASIK might be the perfect solution for you! Utilizing state-of-the-art laser technology, our team can help you see clearly again.

Restore age-related vision loss

Once you hit a certain age, your eyes lose their ability to focus on nearby objects. Reduce your need for reading glasses.

Retain your natural tears

Dry eyes are one of the most common reasons people visit their eye doctor. Our team offers effective treatment for this syndrome to help resolve your discomfort and prevent future issues.

The seeing tissue of the eye

Your retina transforms filtered light into images to be sent to your brain. When this tissue is damaged, objects may appear blurry, which is why a healthy retina is so crucial for your vision.

Early detection for long-term control

Those who suffer from glaucoma have an elevated eye pressure, which can gradually take a toll on their eyesight. When detected early and treated properly, you can slow the diseases.

Rejuvenate your facial appearance

From BOTOX injections to skin care products, our team offers various cosmetic solutions to enhance your appearance and ultimately help you feel more confident about the face you see in the mirror.

Eliminate cloudy vision with laser surgery

Many of us will develop cataracts as we age, and if left untreated, this prevalent condition can lead to progressive vision loss. With laser cataract surgery, we can restore your eye health.

Say goodbye to glasses and contacts

If youre ready to eliminate the need for corrective eyewear, LASIK might be the perfect solution for you! Utilizing state-of-the-art laser technology, our team can help you see clearly again.

Restore age-related vision loss

Once you hit a certain age, your eyes lose their ability to focus on nearby objects. Reduce your need for reading glasses.

Retain your natural tears

Dry eyes are one of the most common reasons people visit their eye doctor. Our team offers effective treatment for this syndrome to help resolve your discomfort and prevent future issues.

The seeing tissue of the eye

Your retina transforms filtered light into images to be sent to your brain. When this tissue is damaged, objects may appear blurry, which is why a healthy retina is so crucial for your vision.

Early detection for long-term control

Those who suffer from glaucoma have an elevated eye pressure, which can gradually take a toll on their eyesight. When detected early and treated properly, you can slow the diseases.

Rejuvenate your facial appearance

From BOTOX injections to skin care products, our team offers various cosmetic solutions to enhance your appearance and ultimately help you feel more confident about the face you see in the mirror.

The quiz below is a great start to finding out if youre a candidate for LASIK vision.

The quiz below is a great start to finding out your Ocular Surface Disease Index (OSDI).

Our team of ophthalmologists and optometrists are highly experienced in providing the latest eye care solutions. We are committed to helping you achieveand maintainclear vision and good eye health through state-of-the-art treatment options.

I was very impressed with both Dr. Scoper and the staff and the results of my procedure are amazing (LASIK). It has been 3 months since my correction in both eyes, the results are amazing. The facility is pretty impressive, and they obviously move a lot of patients through here, but I found the staff to be friendly and caring.

The staff at the Military Highway location are wonderful. They quickly greet you and offer you coffee, tea and yummy shortbread cookies. VA Eye consultants always works to coordinate care with my sister's primary care physician and eye doctor without making us carry records all around town. They also work with our pharmacist to make sure the prescription they provide is covered by her medical plan. We have seen Dr. Whitley, Dr. Salib and Dr. Joly. Wonderful professionals!

From the moment, I made my appointment for a consultation to the very end of the surgery, it was amazing! At my consultation, the entire staff was super friendly and made me feel comfortable. They walked me through all the different test they were going to do on my eyes, answered any question I had and even got to know a little about me. (Which made me feel like a person whether than a potential patient) . I recommend Virginia Eye Consultants for LASIK eye surgery over any other place. You don't just get better vision... You get trusted doctors and staff members who love what they do and do it amazingly well.

Read the original post:
Virginia Eye Consultants - LASIK in Norfolk Virginia Beach ...

Under the direction of Douglas Rhee, MD, who is recognized as one of the nations leading glaucoma experts, University Hospitals Eye Institute delivers superior patient care, advanced clinical technology and pioneering research to seniors, adults and children from five centers of Excellence:

Patients, families and referring physicians benefit from convenient access to superior patient care, advanced clinical technology and pioneering research. We provide a full spectrum of ophthalmology services, including routine eye examinations, medical and surgical care for simple and complex vision disorders, inpatient consultations, diagnostic testing, and simple and complex adult and pediatric contact lens fittings.

At UH Eye Institute, we provide a variety of options because we understand that each person is different. Its why our nationally-renowned experts team up to design customized care plans tailored to meet the individual needs of our patients and their families.

Our physicians also work in partnership with the greater Cleveland community through volunteerism, committee memberships and service as board members and trustees. Our outreach includes Eversight, Cleveland Sight Center, Free Clinic (now Circle Health Services), Ohio Lions, and Prevent Blindness Ohio, which provides over 1,000 free eye exams per year to people without health insurance.

Link:
About Us l Ophthalmology l University Hospitals l ...

University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.

UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.

View UHs policy (PDF) on practitioner-industry relationships.

As of December 31, 2016, Mark Armando Prendes did not disclose any Outside Relationships with Industry.

Go here to see the original:
Mark Armando Prendes MD Doctor Profile & Reviews ...

The Dry Eye Center at University Hospitals Eye Institute offers unique treatments for patients suffering from dry eye disease. Our specialists are trained to treat patients using minimally invasive surgical techniques, as well as with a wide array at-home dry eye treatments and non-invasive therapies conveniently available to patients in our offices.

Our innovative optometrists and ophthalmologists have created the only dry eye center of excellence in the Cleveland area. Our providers are proud to offer a wealth of knowledge and treatments that are unique and effective. We are determined to ease our patient's dry eye symptoms and provide education on how to manage symptoms.

Our use of the Prokera Slim, an amniotic membrane, sets our program apart from other practices. View the video below to learn how Prokera Slim could cure you of your dry eye symptoms.

We take great pride in delivering compassionate and advanced care that is highly sensitive to our patients' individual needs by bringing together trained specialists, including:

To request more information, contact the Dry Eye Center at 216-844-3601.

Continue reading here:
Dry Eye Center | University Hospitals | Cleveland, OH ...

University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.

UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.

View UHs policy (PDF) on practitioner-industry relationships.

As of December 31, 2016, Erik Moffat Ostler did not disclose any Outside Relationships with Industry.

Read more here:
Erik Moffat Ostler MD Doctor Profile & Reviews ...

Dr. Reisman is one of only a few ophthalmologists in Morristown, NJ who is fellowship trained in cornea and refractive laser eye surgery. Having performed more than 15,000 laser eye surgery procedures at his Morris County practice, New Jersey surgeon Dr. Reisman has the experience patients seek, and offers personalized care and a unique treatment plan for each individual.

Are you searching for a cataract surgeon in the Morristown, New Jersey area? Now you can see better after laser cataract surgery with new premium lens implants. Trust the talent of Dr. Reisman to ensure the best results and patient care, offering advances such as laser cataract surgery and premium lens options.

At Morristown Ophthalmology Associates, "Our focus is on your eyes." Our commitment to patient satisfaction is a priority. Dr. Reisman encourages his patients to set up a free consultation and explore laser vision correction options at his Morristown, Morris County office.

Morristown Ophthalmology Associates offers patient financing with Wells Fargo. Please contact our office to learn more about your available options.

Continue reading here:
Morristown Ophthalmology - Cataract Surgery NJ